Edition:
United Kingdom

Anuron Kumar Mitra

India's Sensex breaches 45,000 level as cenbank raises GDP target

7:31am GMT

BENGALURU, Dec 4 India's benchmark stock index crossed 45,000 points for the first time on Friday, as the country's central bank upgraded its GDP target for the current fiscal year and kept interest rates steady in the face of stubbornly high inflation.

Indian shares hit record highs as central bank keeps rates steady

5:41am GMT

BENGALURU, Dec 4 Indian shares hit record highs on Friday after the country's central bank kept interest rates steady in the face of stubbornly high inflation, while also retaining its accommodative monetary policy stance.

India's Gland Pharma jumps 23% in market debut

20 Nov 2020

BENGALURU Shares of India's Gland Pharma got off to a flying start in their market debut on Friday, rising as much as 23% and highlighting a strong appetite for drug stocks.

Indian shares scale record highs in catch-up trade

17 Nov 2020

BENGALURU, Nov 17 Indian shares opened at record highs on Tuesday, playing catch-up with overseas gains after a long holiday weekend and bolstered by news that U.S. drugmaker Moderna Inc's coronavirus vaccine was 94.5% effective in preventing infection.

Indian demand for COVID-19 drug remdesivir rising sharply: Cipla

09 Nov 2020

BENGALURU Demand for COVID-19 antiviral drug remdesivir is rising sharply in India, a top executive at drugmaker Cipla Ltd said on Monday, even as experts remain divided over its effectiveness.

RPT-India trials of Russian Sputnik-V vaccine may end as early as March - Dr Reddy's

29 Oct 2020

BENGALURU, Oct 28 Drugmaker Dr Reddy's Laboratories Ltd on Wednesday rolled out a preliminary timeline for the India trials of Russia's coronavirus vaccine candidate, with the late-stage expected to be completed by as early as March 2021.

India trials of Russian Sputnik-V vaccine may end as early as March: Dr Reddy's

28 Oct 2020

BENGALURU Drugmaker Dr Reddy's Laboratories Ltd on Wednesday rolled out a preliminary timeline for the India trials of Russia's coronavirus vaccine candidate, with the late-stage expected to be completed by as early as March 2021.

India trials of Russian Sputnik-V vaccine may end as early as March - Dr Reddy's

28 Oct 2020

BENGALURU, Oct 28 Drugmaker Dr Reddy's Laboratories Ltd on Wednesday rolled out a preliminary timeline for the India trials of Russia's coronavirus vaccine candidate, with the late-stage expected to be completed by as early as March 2021.

Bharat Biotech in talks to take vaccine candidate global

23 Oct 2020

BENGALURU India's Bharat Biotech is in discussions with more than 10 countries that have shown an interest in a potential COVID-19 vaccine it is developing with a government agency, a company executive told Reuters on Friday.

India's Bharat Biotech in talks to take vaccine candidate global

23 Oct 2020

BENGALURU, Oct 23 India's Bharat Biotech is in discussions with more than 10 countries that have shown an interest in a potential COVID-19 vaccine it is developing with a government agency, a company executive told Reuters on Friday.

World News